Compare HALO & KEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | KEX |
|---|---|---|
| Founded | 1998 | 1921 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 7.6B |
| IPO Year | 2001 | 1994 |
| Metric | HALO | KEX |
|---|---|---|
| Price | $74.99 | $136.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | $78.64 | ★ $137.25 |
| AVG Volume (30 Days) | ★ 1.6M | 521.8K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.92 |
| EPS | 1.22 | ★ 1.50 |
| Revenue | ★ $151,862,000.00 | N/A |
| Revenue This Year | $28.24 | $4.34 |
| Revenue Next Year | $12.56 | $7.61 |
| P/E Ratio | ★ $59.53 | $92.44 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $51.06 | $79.52 |
| 52 Week High | $82.22 | $157.69 |
| Indicator | HALO | KEX |
|---|---|---|
| Relative Strength Index (RSI) | 66.87 | 37.24 |
| Support Level | $62.53 | $118.72 |
| Resistance Level | $79.50 | $137.96 |
| Average True Range (ATR) | 2.20 | 3.25 |
| MACD | 0.30 | -0.51 |
| Stochastic Oscillator | 84.09 | 3.69 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Kirby Corp is a domestic tank barge operator, transporting bulk liquid products throughout three United States coasts. The Company transports petrochemicals, liquid cargoes, inland waterway systems, and dry bulk cargoes. The Company conducts operations in two reportable business segments: The Marine transportation segment which provides marine transportation services, operating tank barges and towing vessels transporting bulk liquid products, and the Distribution and services segment, which provides after-market service, and genuine replacement parts for engines, transmissions, reduction gears, and power generation equipment used in oil and gas and commercial and industrial applications. The company's majority revenue is generated from the Marine Transportation segment.